JPH06256314A - Method for synthesizing 2-butyl-4-chloro-5-formylimidazole - Google Patents

Method for synthesizing 2-butyl-4-chloro-5-formylimidazole

Info

Publication number
JPH06256314A
JPH06256314A JP5066051A JP6605193A JPH06256314A JP H06256314 A JPH06256314 A JP H06256314A JP 5066051 A JP5066051 A JP 5066051A JP 6605193 A JP6605193 A JP 6605193A JP H06256314 A JPH06256314 A JP H06256314A
Authority
JP
Japan
Prior art keywords
butyl
chloro
formylimidazole
added
mol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5066051A
Other languages
Japanese (ja)
Other versions
JP2811525B2 (en
Inventor
Shozo Miura
昌三 三浦
Suzuko Sato
鈴子 佐藤
Tomoko Takashige
知子 高重
Takayuki Murai
孝行 村井
Tokuichi Saeki
篤一 佐伯
Naoki Kano
直喜 狩野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shikoku Chemicals Corp
Original Assignee
Shikoku Chemicals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shikoku Chemicals Corp filed Critical Shikoku Chemicals Corp
Priority to JP5066051A priority Critical patent/JP2811525B2/en
Publication of JPH06256314A publication Critical patent/JPH06256314A/en
Application granted granted Critical
Publication of JP2811525B2 publication Critical patent/JP2811525B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Abstract

PURPOSE:To mass-produce 2-butyl-4-chloro-5-formylimidazole useful as an intermediate for medicines. CONSTITUTION:2-Butyl-4-chloro-5-methylimidazole is oxidized with a persulfate in water or a solvent containing water in the presence of a metal salt under heating to synthesize 2-butyl-4-chlori-5-formylimidazole.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】この発明は、医薬品の中間体等と
して有用な2−ブチル−4−クロロ−5−ホルミルイミ
ダゾールの新規な製造法に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel method for producing 2-butyl-4-chloro-5-formylimidazole which is useful as an intermediate for pharmaceuticals.

【0002】[0002]

【従来の技術】2−ブチル−4−クロロ−5−フォルミ
ルイミダゾールの製法として、特開昭63−23868
号公報に2−ブチル−5−ヒドロキシメチルイミダゾー
ルとN−クロロサクシンイミドなどの塩素化剤を反応さ
せて2−ブチル−4−クロロ−5−ヒドロキシメチルイ
ミダゾールを合成し、これを二酸化マンガンなどの酸化
剤を反応させる方法、特公昭61−1022号公報に2
−アミノ−3、3−ジクロロアクリロニトリルとバレロ
アルデヒドを反応させてシフ塩基とし、これを塩酸およ
び次いで水で処理をする方法がそれぞれ記載されてい
る。
2. Description of the Related Art A method for producing 2-butyl-4-chloro-5-formylimidazole is disclosed in JP-A-63-238868.
In the publication, 2-butyl-5-hydroxymethylimidazole is reacted with a chlorinating agent such as N-chlorosuccinimide to synthesize 2-butyl-4-chloro-5-hydroxymethylimidazole. A method of reacting an oxidizing agent is disclosed in Japanese Patent Publication No. 61-2022.
-Amino-3,3-dichloroacrylonitrile and valeroaldehyde are reacted to give a Schiff base, which is treated with hydrochloric acid and then with water, respectively.

【0003】しかしながら、前者の方法によれば原料で
ある2−ブチル−5−ヒドロキシメチルイミダゾール
は、液体アンモニア中でイミディトエステルとジヒドロ
キシアセトンを反応させる極めて難しい処理を伴うもの
であり、また後者の方法において使用されている2−ア
ミノ−3、3−ジクロロアクリロニトリルも、その合成
が著しく煩雑であるなどの問題があり、2−ブチル−4
−クロロ−5−フォルミルイミダゾールの簡便な合成方
法が望まれていた。
According to the former method, however, the starting material, 2-butyl-5-hydroxymethylimidazole, involves an extremely difficult treatment of reacting the imidite ester with dihydroxyacetone in liquid ammonia, and the latter method. 2-Amino-3,3-dichloroacrylonitrile used in the method also has a problem that the synthesis thereof is extremely complicated, and 2-butyl-4
A convenient method for synthesizing -chloro-5-formylimidazole has been desired.

【0004】[0004]

【発明が解決しようとする課題】この発明の目的は、医
薬品の中間体等として有用な2−ブチル−4−クロロ−
5−フォルミルイミダゾール化合物を安価に且つ大量に
製造しうる方法を提供することにある。
The object of the present invention is 2-butyl-4-chloro-, which is useful as an intermediate for pharmaceuticals.
An object of the present invention is to provide a method capable of inexpensively producing a 5-formylimidazole compound in a large amount.

【0005】[0005]

【課題を解決するための手段】本発明者等は、このよう
な事情に鑑み種々の試験を重ねた結果、2−ブチル−4
−クロロ−5−メチルイミダゾールを水あるいは水を含
む溶媒中において触媒としての金属塩の存在下、過硫酸
塩を加えて酸化させることにより、容易に2−ブチル−
4−クロロ−5−フォルミルイミダゾール化合物が得ら
れることを知見し、本発明方法を完遂するに至った。本
発明方法を反応式を用いて表すと以下のとおりである。
The inventors of the present invention have conducted various tests in view of such circumstances, and as a result, 2-butyl-4
2-Chloro-5-methylimidazole can be easily oxidized by adding persulfate to oxidize 2-butyl-5-methylimidazole in water or a solvent containing water in the presence of a metal salt as a catalyst.
It was found that a 4-chloro-5-formylimidazole compound was obtained, and the method of the present invention was completed. The method of the present invention is represented by the following reaction formula.

【0006】[0006]

【化1】 [Chemical 1]

【0007】本発明の2−ブチル−4−クロロ−5−フ
ォルミルイミダゾール化合物を合成する方法は、2−ブ
チル−4−クロロ−5−メチルイミダゾールを水あるい
は水を含む溶媒に溶かし、この溶液に触媒として作用す
る金属塩を加えたのち、さらに過硫酸塩あるいは過硫酸
塩を含む水溶液を加えて、室温〜100℃の温度範囲、
好ましくは50〜100℃の温度範囲に加熱して酸化さ
せることである。
The method for synthesizing the 2-butyl-4-chloro-5-formylimidazole compound of the present invention is as follows. 2-butyl-4-chloro-5-methylimidazole is dissolved in water or a solvent containing water, and this solution is used. After a metal salt acting as a catalyst is added to, a persulfate or an aqueous solution containing a persulfate is further added, and the temperature range of room temperature to 100 ° C.
It is preferable to oxidize by heating in a temperature range of 50 to 100 ° C.

【0008】本発明方法に使用される溶剤としては、水
と相溶し、かつ酸化に対して安定である溶剤が好まし
く、その代表的なものとしては酢酸、DMF、ジオキサ
ン、エタノール等である。
The solvent used in the method of the present invention is preferably a solvent which is compatible with water and stable against oxidation, and typical examples thereof include acetic acid, DMF, dioxane, ethanol and the like.

【0009】本発明方法の実施において使用される代表
的な触媒としては、鉄、銀、銅、コバルト、マンガン、
バナジウム等の金属塩であり、例えば塩化第一鉄、塩化
第二鉄、硫酸第一鉄、硫酸第二鉄、硝酸銀、硫酸銅等が
用いられる。添加される触媒の量は原料である2−ブチ
ル−4−クロロ−5−メチルイミダゾールに対して0.
1〜50重量%の範囲であり、好ましくは0.5〜10
重量%である。
Typical catalysts used in the practice of the method of the present invention include iron, silver, copper, cobalt, manganese,
It is a metal salt such as vanadium, and for example, ferrous chloride, ferric chloride, ferrous sulfate, ferric sulfate, silver nitrate, copper sulfate and the like are used. The amount of catalyst added was 0. 0 with respect to the starting material, 2-butyl-4-chloro-5-methylimidazole.
It is in the range of 1 to 50% by weight, preferably 0.5 to 10
% By weight.

【0010】本発明方法の実施において用いられる過硫
酸塩としては、過硫酸ナトリウム、過硫酸カリウム等の
過硫酸アルカリ及び過硫酸アンモニウム等である。添加
される過硫酸塩の量は、原料である2−ブチル−4−ク
ロロ−5−メチルイミダゾールに対して0.5〜4.0
倍モルであり、好ましくは1.0〜2.5倍モルであ
る。過硫酸塩の量が0.5倍モルより少なくなると未反
応物が多く残存し、逆に4.0倍モルより多くなると生
成した目的物が更に酸化を受けて副生成物が多くなり精
製が難しくなる。
The persulfates used in the method of the present invention include alkali persulfates such as sodium persulfate and potassium persulfate, and ammonium persulfate. The amount of persulfate added is 0.5 to 4.0 with respect to 2-butyl-4-chloro-5-methylimidazole as a raw material.
The molar amount is double, and preferably 1.0 to 2.5 times. If the amount of persulfate is less than 0.5 times the molar amount, a large amount of unreacted material remains, and if the amount of the persulfate is more than 4.0 times the molar amount, the produced target product is further oxidized and the amount of by-products increases, resulting in purification It gets harder.

【0011】また必要に応じて、硫酸、塩酸、硝酸、酢
酸等の酸性物質を溶剤に添加しても差し支えなく、なか
でも硫酸が好適である。このときの添加量は0.1〜
2.0倍当量であり、好ましくは0.5〜1.0倍当量
である。
If necessary, an acidic substance such as sulfuric acid, hydrochloric acid, nitric acid or acetic acid may be added to the solvent, and sulfuric acid is particularly preferable. The addition amount at this time is 0.1
It is 2.0 times equivalent and preferably 0.5 to 1.0 times equivalent.

【0012】なお、反応物中には目的物の2−ブチル−
4−クロロ−5−フォルミルイミダゾール化合物以外
に、原料の2−ブチル−4−クロロ−5−メチルイミダ
ゾール並びに副生成物である2−ブチル−4−クロロ−
5−ヒドロキシメチルイミダゾール及び2−ブチル−4
−クロロイミダゾール−5−カルボン酸等が含まれる。
2−ブチル−4−クロロ−5−ヒドロキシメチルイミダ
ゾールは、適当な酸化剤を用いて酸化させることによ
り、容易に2−ブチル−4−クロロ−5−フォルミルイ
ミダゾールが得られ、また原料の2−ブチル−4−クロ
ロ−5−メチルイミダゾールも適当な方法によって回収
することが可能である。
The reaction product contains 2-butyl-
In addition to the 4-chloro-5-formylimidazole compound, 2-butyl-4-chloro-5-methylimidazole which is a raw material and 2-butyl-4-chloro- which is a by-product.
5-hydroxymethylimidazole and 2-butyl-4
-Chloroimidazole-5-carboxylic acid and the like are included.
2-Butyl-4-chloro-5-hydroxymethylimidazole can be easily obtained by oxidation with a suitable oxidizing agent to give 2-butyl-4-chloro-5-formylimidazole. -Butyl-4-chloro-5-methylimidazole can also be recovered by any suitable method.

【0013】反応混合物から目的物の2−ブチル−4−
クロロ−5−フォルミルイミダゾールを単離精製する方
法は常法に従って行われるが、例えば反応混合物にアル
カリ水溶液を加えて塩基性としたのち、適当な溶剤を用
いて抽出し、この抽出液を減圧乾固し、さらに乾固物を
適当な溶剤を用いて再結晶してもよく、また前記の抽出
操作によって得られる乾固物を減圧蒸留に付したのち、
得られた留出物を適当な溶剤を用いて再結晶してもよ
い。
From the reaction mixture, the desired product 2-butyl-4-
The method for isolating and purifying chloro-5-formylimidazole is carried out according to a conventional method. For example, an alkaline aqueous solution is added to the reaction mixture to make it basic, followed by extraction with a suitable solvent, and the extract is decompressed. After drying to dryness, the dry solid may be recrystallized using a suitable solvent, or after subjecting the dry solid obtained by the extraction operation to vacuum distillation,
The distillate obtained may be recrystallized using a suitable solvent.

【0014】他の方法としては、抽出操作によって得ら
れる乾固物を溶剤に溶かし、この溶液に乾固物と同量な
いし5倍量の二酸化マンガンを加え、室温下において2
時間以上、好ましくは10時間以上攪拌したのち二酸化
マンガンを濾別し、濾液を濃縮して濃縮物を適当な溶剤
を用いて再結晶するか、あるいは前記の濃縮物を蒸留に
付したのち留出物を再結晶する方法により単離精製する
ことができる。
As another method, the dry solid obtained by the extraction operation is dissolved in a solvent, and manganese dioxide of the same amount to 5 times as the dry solid is added to the solution, and the mixture is allowed to stand at room temperature for 2 minutes.
After stirring for at least 10 hours, preferably at least 10 hours, the manganese dioxide is filtered off, the filtrate is concentrated and the concentrate is recrystallized with a suitable solvent, or the concentrate is distilled and then distilled. It can be isolated and purified by a method of recrystallizing the product.

【0015】[0015]

【実施例】以下、本発明を実施例及び参考例によって具
体的に説明する。 (参考例)2−ブチル−4−クロロ−5−メチルイミダ
ゾールの合成 2−ブチル−4−メチルイミダゾール138g(1.0
モル)をクロロホルム370mlに溶解し、これにN−
クロロサクシンイミド146g(1.1モル)を少しづ
つ1時間かけて添加し、さらに30〜40℃で2時間熱
成した。
EXAMPLES The present invention will be specifically described below with reference to examples and reference examples. (Reference Example) Synthesis of 2-butyl-4-chloro-5-methylimidazole 138 g (1.0 g) of 2-butyl-4-methylimidazole
Mol) was dissolved in 370 ml of chloroform, and N-
146 g (1.1 mol) of chlorosuccinimide was added little by little over 1 hour, and the mixture was further heated at 30 to 40 ° C. for 2 hours.

【0016】反応終了後析出した琥珀酸イミドを濾別
し、濾液に炭酸ナトリウム水溶液を加えて激しく攪拌し
たのち、分液してクロロホルム層を分取し、これを減圧
凝縮して得られた乾固物をアセトンで抽出した。次いで
抽出液を濃縮して少量のアセトンを用いて再結晶し、目
的物の2−ブチル−4−クロロ−5−メチルイミダゾー
ル80g(収率46モル%)が得られた。
After completion of the reaction, the succinimide precipitated was filtered off, an aqueous solution of sodium carbonate was added to the filtrate, and the mixture was vigorously stirred, and then separated to separate a chloroform layer, which was condensed under reduced pressure to obtain a dry sample. The solid was extracted with acetone. Next, the extract was concentrated and recrystallized with a small amount of acetone to obtain 80 g of the desired product, 2-butyl-4-chloro-5-methylimidazole (yield 46 mol%).

【0017】(実施例1)2−ブチル−4−クロロ−5
−メチルイミダゾール172.5g(1.0モル)を濃
硫酸100gと水1660mlからなる硫酸水溶液に溶
かし、これに硫酸銅8.6gを加え、室温において過硫
酸ナトリウム524g(2.2モル)と水1660ml
からなる過硫酸ナトリウム水溶液を15分かけて徐々に
滴下し、次いで1時間加熱還流をした。
Example 1 2-Butyl-4-chloro-5
-Methylimidazole 172.5 g (1.0 mol) is dissolved in a sulfuric acid aqueous solution consisting of concentrated sulfuric acid 100 g and water 1660 ml, copper sulphate 8.6 g is added thereto, and at room temperature sodium persulfate 524 g (2.2 mol) and water are added. 1660 ml
An aqueous solution of sodium persulfate consisting of was gradually added dropwise over 15 minutes, and then the mixture was heated under reflux for 1 hour.

【0018】得られた反応物に炭酸ナトリウム370g
(3.5モル)を加えて塩基性とし、遊離してくるオイ
ル状物質を酢酸エチルを用いて液々抽出し、抽出液を活
性白土に通過させたのち、乾固して乾固物120gを得
た。この乾固物を液体クロマトグラフィーで検査したと
ころ49モル%の収率で2−ブチル−4−クロロ−5−
フォルミルイミダゾール化合物が生成していることが判
った。更に、この乾固物を再結晶精製したところ、純度
96.5%の2−ブチル−4−クロロ−5−フォルミル
イミダゾール76.5g(収率41モル%)が得られ
た。なお、純度は液体クロマトグラフィーによる分析値
である。
370 g of sodium carbonate was added to the obtained reaction product.
(3.5 mol) was added to make it basic, and the oily substance that had liberated was extracted with ethyl acetate by liquid, and after passing the extract through activated clay, it was dried to 120 g dry solid. Got The dry solid was examined by liquid chromatography to give 2-butyl-4-chloro-5-yield of 49 mol%.
It was found that a formyl imidazole compound was produced. Further, the dried solid was purified by recrystallization to obtain 76.5 g (yield 41 mol%) of 2-butyl-4-chloro-5-formylimidazole having a purity of 96.5%. The purity is an analysis value by liquid chromatography.

【0019】(実施例2)2−ブチル−4−クロロ−5
−メチルイミダゾール172.5g(1.0モル)を濃
硫酸50gと水1660mlからなる硫酸水溶液に溶か
し、この溶液に10gの硝酸銀を加えて加熱沸騰させ、
次いでこれに過硫酸カリウム594g(2.2モル)を
少しづつ添加し、1時間加熱還流した。
Example 2 2-Butyl-4-chloro-5
172.5 g (1.0 mol) of methylimidazole was dissolved in a sulfuric acid aqueous solution consisting of 50 g of concentrated sulfuric acid and 1660 ml of water, 10 g of silver nitrate was added to this solution, and the mixture was heated to boiling,
Then, 594 g (2.2 mol) of potassium persulfate was added thereto little by little, and the mixture was heated under reflux for 1 hour.

【0020】得られた反応物を冷却したのち、実施例1
と同様の方法により処理したところ、乾固物130gが
得られた。これを液体クロマトグラフィーにより検査し
たところ51モル%の収率で2−ブチル−4−クロロ−
5−フォルミルイミダゾール化合物が生成していること
が判った。さらに、この乾固物を再結晶精製し、純度9
7.0%の2−ブチル−4−クロロ−5−フォルミルイ
ミダゾール74.6g(収率40モル%)が得られた。
After cooling the resulting reaction product, Example 1
When treated in the same manner as in (1), 130 g of a dry solid was obtained. When this was examined by liquid chromatography, 2-butyl-4-chloro- was obtained in a yield of 51 mol%.
It was found that a 5-formylimidazole compound was produced. Further, the dried solid was purified by recrystallization to obtain a purity of 9
74.6 g (yield 40 mol%) of 7.0% 2-butyl-4-chloro-5-formylimidazole was obtained.

【0021】(実施例3)2−ブチル−4−クロロ−5
−メチルイミダゾール172.5g(1.0モル)を濃
硫酸100gと水1660mlからなる硫酸水溶液に溶
かし、この溶液に塩化第二鉄8.5gを加えて加熱し、
還流下過硫酸アンモニウム501g(2.2モル)を1
時間かけて添加し、さらに3時間加熱を続けて反応を熱
成させた。
Example 3 2-Butyl-4-chloro-5
172.5 g (1.0 mol) of methyl imidazole was dissolved in a sulfuric acid aqueous solution consisting of 100 g of concentrated sulfuric acid and 1660 ml of water, and 8.5 g of ferric chloride was added to this solution and heated,
Under reflux, 501 g (2.2 mol) of ammonium persulfate was added to 1
The mixture was added over time, and heating was continued for another 3 hours to allow the reaction to heat up.

【0022】得られた反応混合物を実施例1と同様の方
法により処理したところ、乾固物150gが得られ、こ
れを液体クロマトグラフィーにより検査したところ44
モル%(82.1g)の収率で2−ブチル−4−クロロ
−5−フォルミルイミダゾール化合物及び21モル%の
2−ブチル−4−クロロ−5−ヒドロキシメチルイミダ
ゾールが含まれていることが判った。
When the obtained reaction mixture was treated in the same manner as in Example 1, 150 g of a dry solid was obtained, which was examined by liquid chromatography.
2-butyl-4-chloro-5-formylimidazole compound and 21 mol% 2-butyl-4-chloro-5-hydroxymethylimidazole are included in a yield of mol% (82.1 g). understood.

【0023】前記乾固物をアセトン1500mlに溶か
し、これに二酸化マンガン粉末200gを加え、室温下
15時間攪拌たのち、二酸化マンガンを濾別し、濾液を
濃縮して濃縮物を常法に従って精製したところ、2−ブ
チル−4−クロロ−5−フォルミルイミダゾール10
0.7g(54モル%)が得られた。さらにイソプロピ
ルアルコールを用いて再結晶して、純度97.5%の2
−ブチル−4−クロロ−5−フォルミルイミダゾール8
4.0g(収率45モル%)が得られた。
The dried solid was dissolved in 1500 ml of acetone, and 200 g of manganese dioxide powder was added to the solution. After stirring at room temperature for 15 hours, manganese dioxide was filtered off, and the filtrate was concentrated to purify the concentrate according to a conventional method. However, 2-butyl-4-chloro-5-formyl imidazole 10
0.7 g (54 mol%) was obtained. Recrystallize with isopropyl alcohol to obtain 2 with a purity of 97.5%.
-Butyl-4-chloro-5-formyl imidazole 8
4.0 g (yield 45 mol%) was obtained.

【0024】[0024]

【発明の効果】本発明方法によれば、医薬品の中間体等
として有用な2−ブチル−4−クロロ−5−フォルミル
イミダゾール化合物を比較的安価な原料を用いて製造す
ることができ、且つ製造工程における処理が容易である
ため、工業的規模の実施に適している。
Industrial Applicability According to the method of the present invention, a 2-butyl-4-chloro-5-formylimidazole compound useful as an intermediate for pharmaceuticals can be produced using relatively inexpensive raw materials, and It is suitable for industrial scale implementation because it is easy to process in the manufacturing process.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 佐伯 篤一 香川県三豊郡大野原町大字大野原1472番地 (72)発明者 狩野 直喜 香川県丸亀市土器町東7丁目164番地 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Atsushi Saeki 1472 Onohara, Onohara-cho, Mitoyo-gun, Kagawa Prefecture (72) Inventor Naoki Kano 7164, Higashi-cho, Marugame, Kagawa Prefecture

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 2−ブチル−4−クロロ−5−メチルイ
ミダゾールを水あるいは水を含む溶媒中において金属塩
の存在下、過硫酸塩を加えて酸化させることを特徴とす
る2−ブチル−4−クロロ−5−フォルミルイミダゾー
ルの合成方法。
1. 2-Butyl-4-chloro-5-methylimidazole is characterized in that persulfate is added and oxidized in the presence of a metal salt in water or a solvent containing water. -Method for synthesizing chloro-5-formyl imidazole.
JP5066051A 1993-03-01 1993-03-01 Method for synthesizing 2-butyl-4-chloro-5-formylimidazole Expired - Fee Related JP2811525B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5066051A JP2811525B2 (en) 1993-03-01 1993-03-01 Method for synthesizing 2-butyl-4-chloro-5-formylimidazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5066051A JP2811525B2 (en) 1993-03-01 1993-03-01 Method for synthesizing 2-butyl-4-chloro-5-formylimidazole

Publications (2)

Publication Number Publication Date
JPH06256314A true JPH06256314A (en) 1994-09-13
JP2811525B2 JP2811525B2 (en) 1998-10-15

Family

ID=13304695

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5066051A Expired - Fee Related JP2811525B2 (en) 1993-03-01 1993-03-01 Method for synthesizing 2-butyl-4-chloro-5-formylimidazole

Country Status (1)

Country Link
JP (1) JP2811525B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106083713A (en) * 2016-07-15 2016-11-09 浙江工业大学 A kind of chemical synthesis process of quinoline () quinoline 2 benzaldehyde compound
CN111592495A (en) * 2020-07-06 2020-08-28 上海启讯医药科技有限公司 Preparation method of 2-n-butyl-4-chloro-5-formylimidazole

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106083713A (en) * 2016-07-15 2016-11-09 浙江工业大学 A kind of chemical synthesis process of quinoline () quinoline 2 benzaldehyde compound
CN111592495A (en) * 2020-07-06 2020-08-28 上海启讯医药科技有限公司 Preparation method of 2-n-butyl-4-chloro-5-formylimidazole

Also Published As

Publication number Publication date
JP2811525B2 (en) 1998-10-15

Similar Documents

Publication Publication Date Title
JP2018523662A (en) Novel process for producing chromanone derivatives
JP2811525B2 (en) Method for synthesizing 2-butyl-4-chloro-5-formylimidazole
JP2620437B2 (en) Process for producing ω-hydroxy- (ω-3) -ketonitrile and ω-hydroxy fatty acid
JPH0136462B2 (en)
US6797844B2 (en) Process for producing phthalaldehyde
JP3796280B2 (en) Process for producing 1- (2-chlorophenyl) -5 (4H) -tetrazolinone
JPS62298546A (en) Production of anisaldehyde
JP3468543B2 (en) 2-butyl-4-chloro-5-methylimidazole and method for synthesizing the same
RU2026857C1 (en) Method of synthesis of 2-methoxyisobutylisocyanide
JPS6317869A (en) Production of 2-lower alkyl-4-amino-5-formylpyrimidine
JP2849325B2 (en) Method for synthesizing 4-halo-5- (hydroxymethyl) imidazole compound
JP3159860B2 (en) Method for synthesizing 4,5-diformylimidazole compound and novel imidazole compound
JP3852491B2 (en) 2-cyanopiperazine and method for producing the same
JP3272340B2 (en) Method for producing 1-[(cyclopent-3-en-1-yl) methyl] -5-ethyl-6- (3,5-dimethylbenzoyl) -2,4-pyrimidinedione
JPH0527617B2 (en)
JP2002212149A (en) METHOD FOR PRODUCING TETRAALKYLAMMONIUM FLUORIDE AND METHOD FOR PRODUCING beta-HYDROXYKETONE BY USING THE SAME
JPS5840939B2 (en) Method for producing cyclohexanedione derivatives
JP2001048826A (en) Production of 1-phenyl-1,3-butanedione
JPH09227490A (en) Production of 3-(or 4-)cyanobenzaldehyde
JP3216674B2 (en) 5-Alkoxy-2,3,4,5-tetrahydro-3-oxoisoxazole and process for producing the same
JP2907475B2 (en) Process for producing (1,2,3-thiadiazol-4-yl) carbaldehyde and intermediate
JPH0259545A (en) 3-amino-2-hydroxy-1-nitrobutane derivative and production of alpha-hydroxy-beta-amino acid
JP2002302484A (en) New imidazole derivative and method for producing the same
JPS62228041A (en) Production of carboxylic acid derivative
JPH03251558A (en) Production of n-(3',4'-dimethoxycinnamoyl)anthranilic acid

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees